• 

  Frontotemporal Dementia Treatments: What Helps Now and What’s Coming Next
• 

  GLP-1 Semaglutide Fails to Slow Alzheimer’s Despite Biomarker Changes
• 

  The Challenge of Diagnosing Frontotemporal Dementia
• 

  Shingles Vaccine Linked to Lower Dementia Risk — What to Know
• 

  Vascular Dementia 101: Causes, Risk Factors, Symptoms
• 

  POINTER: Lifestyle Shifts Improve Sleep and Brain Blood Vessels
• 

  FTD 101: Your Being Patient Primer on Frontotemporal Dementia
• 

  Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer’s Trial
• 

  Digital Twins: The Sci-Fi Innovation Behind New Personalized Disease Treatments
• 

  Potential First: Pill for Lewy Body Dementia Heads to a Phase 3 Trial
• 

  FDA Clears Blood Test to Help Doctors Rule Out Alzheimer’s
• 

  When Insurance Refused to Cover His Alzheimer’s Treatment, He Found Another Way
• 

  Alzheimer’s Drug Leqembi Approved in Canada
• 

  Cassava Fraud Case Dismissed, Closing a Chapter in Alzheimer’s Drug Saga
• 

  NIH Alzheimer’s Research Funding Is Back — for 49% Fewer Projects

Previous345Next